Sign Up to like & get
recommendations!
0
Published in 2018 at "Kidney international"
DOI: 10.1016/j.kint.2017.09.018
Abstract: The prospects for complement-targeted therapy in ANCA-associated vasculitis have been enhanced by a recent clinical trial in which C5a receptor 1 (C5aR1) inhibition safely replaced glucocorticoids in induction treatment. C5aR1 primes neutrophils for activation by…
read more here.
Keywords:
myeloperoxidase;
anti myeloperoxidase;
c5a receptor;
inhibition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Transplant immunology"
DOI: 10.1016/j.trim.2022.101559
Abstract: BACKGROUND C5a promotes alloreactivity via the C5a receptor 1 (C5aR1) on immune cells, but this has not been confirmed in the case of small intestine transplantation immunity. In the present study, we examined the effect…
read more here.
Keywords:
group;
c5a receptor;
macrophage;
c5a ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-236236
Abstract: Granulomatosis with polyangiitis (GPA) is a rare antineutrophil cytoplasm antibody-associated vasculitis. Several therapeutic advances have occurred over the past two decades, but relapse rate remains high and refractory cases are not uncommon. Here, we present…
read more here.
Keywords:
receptor inhibitor;
granulomatosis polyangiitis;
c5a receptor;
Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0173749
Abstract: We investigated effects of 7-oxygenated cholesterol derivatives present in atherosclerotic lesions, 7α-hydroxycholesterol (7αOHChol), 7β-hydroxycholesterol (7βOHChol), and 7-ketocholesterol (7K), on IL-8 expression. Transcript levels of IL-8 and secretion of its corresponding gene product by monocytes/macrophages were…
read more here.
Keywords:
monocyte macrophage;
expression;
c5a receptor;
ohchol ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.947071
Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disease of the brain causing either familial or sporadic dementia. We have previously administered the modified C5a receptor agonist (EP67) for a short period to a transgenic mouse…
read more here.
Keywords:
alzheimer disease;
cognitive impairment;
c5a receptor;
model ... See more keywords